뇌 건강보조제 시장 규모, 점유율, 성장 및 세계 산업 분석 : 종류별, 용도별, 지역별 인사이트와 예측(2026-2034년)

Growth Factors of brain health supplements Market

The global brain health supplements market is gaining steady momentum as awareness of cognitive health, mental wellness, and age-related neurological conditions continues to rise worldwide. According to Fortune Business Insights, the brain health supplements market was valued at USD 6.74 billion in 2025 and is projected to grow to USD 7.24 billion in 2026. Supported by increasing adoption among aging populations and younger consumers alike, the market is forecast to reach USD 13.69 billion by 2034, expanding at a CAGR of 8.00% during the 2026-2034 forecast period.

North America dominated the global market with a 48.86% share in 2025, driven by high awareness of cognitive disorders, strong purchasing power, and widespread acceptance of dietary supplements for mental wellness.

Market Overview

Brain health supplements are dietary products designed to support cognitive function, memory, focus, and mental clarity. These supplements typically contain vitamins, minerals, botanical extracts, and nootropic ingredients that assist in maintaining brain performance. The rising aging population, increasing prevalence of diet-related chronic diseases, and growing incidence of cognitive impairment and Alzheimer's disease are major factors supporting market growth.

In addition, individuals following restricted or specialized diets and people managing chronic medical conditions are increasingly adopting these supplements to support overall brain health.

Impact of COVID-19

The COVID-19 pandemic positively impacted the brain health supplements market by accelerating conversations around mental health, stress, anxiety, and emotional well-being. Increased exposure to mental health challenges during lockdowns led to higher consumer interest in supplements supporting cognitive performance and mood balance. Moreover, the pandemic encouraged individuals to prioritize preventive healthcare and quality of life, boosting demand for brain health supplements.

Strategic marketing campaigns and collaborations with mental health advocates further enhanced product visibility during this period.

Brain Health Supplements Market Trends

Introduction of New Dietary Ingredients

Manufacturers are increasingly focusing on introducing novel, scientifically backed dietary ingredients to improve the safety and efficacy of brain health supplements. Regulatory approvals for new ingredients are enabling companies to expand their product portfolios and strengthen consumer trust.

For instance, in August 2023, AKER BIOMARINE received U.S. FDA approval for LYSOVETA, a dietary ingredient designed to support cognitive decline during aging. Such approvals play a critical role in driving innovation and adoption in the market.

Market Growth Factors

Expansion of Product Portfolios and New Market Entrants

Growing awareness of mental health among younger populations has reduced stigma around cognitive disorders and encouraged proactive health management. This shift has attracted new entrants, private-label manufacturers, and investors into the market. Demand for supplements containing naturally sourced ingredients is further accelerating market entry.

In addition, the availability of contract manufacturing services has made it easier for emerging brands to launch brain health supplement products at competitive prices.

Rising Adoption in the Sports Industry

The sports industry is emerging as an important consumer segment for brain health supplements. Athletes increasingly recognize the role of nutrition in enhancing focus, reaction time, and mental endurance. Nootropic ingredients are being incorporated into sports nutrition products to support cognitive performance and overall athletic outcomes.

Collaborations between supplement manufacturers and sports organizations are further supporting market demand.

Restraining Factors

Despite growing demand, the market faces challenges such as high product costs, limited clinical evidence for some supplements, and lack of awareness among consumers and healthcare professionals. Concerns regarding side effects, unapproved ingredients, and inconsistent labeling also restrict adoption in certain regions.

Additionally, limited affordability in low-income countries acts as a barrier to widespread market penetration.

Segmentation Analysis

By Product Type

The market is segmented into nootropic supplements and vitamins & minerals.

The vitamins & minerals segment accounted for a dominant 79.05% market share in 2026, driven by widespread use across all age groups and strong consumer trust in essential nutrients.

Nootropic supplements are projected to grow at the fastest rate due to increasing demand for cognitive enhancement products.

By Dosage Form

Based on dosage form, the market includes tablets, capsules, and others.

The capsules segment dominated with a 69.40% share in 2026, supported by ease of consumption, clean-label appeal, and formulation flexibility.

By Application

The market is segmented into cognitive function, stress & anxiety, and others.

The stress & anxiety segment led the market with a 45.43% share in 2026, reflecting rising mental stress levels globally.

By Distribution Channel

Hospital pharmacies, drug stores & retail pharmacies, online channels, and others form the distribution landscape.

Hospital pharmacies accounted for a 43.75% share in 2026, while online channels are expected to grow rapidly due to convenience and accessibility.

Regional Insights

North America remained the leading region in 2025 and 2026, supported by high diagnosis rates of neurological disorders and strong consumer spending on supplements.

Europe held a substantial share due to technological advancements and cognitive monitoring tools.

Asia Pacific is expected to witness strong growth driven by expanding e-commerce platforms and rising awareness in emerging economies.

Competitive Landscape

The market is fragmented, with companies focusing on new product launches, collaborations, and brand expansion. Key players include Reckitt Benckiser Group PLC, Natrol LLC, Neurohacker Collective, Onnit Labs, and Natural Factors USA, among others.

Conclusion

The global brain health supplements market, valued at USD 6.74 billion in 2025, increased to USD 7.24 billion in 2026 and is projected to reach USD 13.69 billion by 2034. Market growth is supported by rising awareness of cognitive health, increasing adoption across age groups, product innovation, and expanding distribution channels.

Segmentation By Product Type

• Nootropic Supplements
  • Dietary Supplements
  • Herbal Extracts
  • Others (Synthetic compounds, prescription drugs)
• Vitamins & Minerals

By Dosage Form

• Tablets
• Capsules
• Others

By Application

• Cognitive Function
• Stress & Anxiety
• Others

By Distribution Channel

• Hospital Pharmacies
• Drug Store & Retail Pharmacies
• Online Channel
• Others

By Region

• North America (By Product Type, By Dosage Form, By Application, By Distribution Channel, and By Country)
  • U.S.
  • Canada
• Europe (By Product Type, By Dosage Form, By Application, By Distribution Channel, and By Country/Sub-Region)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Product Type, By Dosage Form, By Application, By Distribution Channel, and By Country/Sub-Region)
  • Japan
  • China
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Rest of the World (By Product Type, By Dosage Form, By Application, and By Distribution Channel)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Mental Disorders, By Key Countries/Regions, 2025
• 4.2. New Product Launches, By Key Players
• 4.3. Key Industry Developments - Mergers, Acquisitions & Partnerships
• 4.4. Impact of COVID-19 on the Market

5. Global Brain Health Supplements Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Product Type
  • 5.1.1. Nootropic Supplements
    • 5.1.1.1. Dietary Supplements
    • 5.1.1.2. Herbal Extracts
    • 5.1.1.3. Others
  • 5.1.2. Vitamins & Minerals
• 5.2. Market Analysis, Insights and Forecast - By Dosage Form
  • 5.2.1. Tablets
  • 5.2.2. Capsules
  • 5.2.3. Others
• 5.3. Market Analysis, Insights and Forecast - By Application
  • 5.3.1. Cognitive Function
  • 5.3.2. Stress & Anxiety
  • 5.3.3. Others
• 5.4. Market Analysis, Insights and Forecast - By Distribution Channel
  • 5.4.1. Hospital Pharmacies
  • 5.4.2. Drug Store & Retail Pharmacies
  • 5.4.3. Online Channel
  • 5.4.4. Others
• 5.5. Market Analysis, Insights and Forecast - By Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Rest of the World

6. North America Brain Health Supplements Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Product Type
  • 6.1.1. Nootropic Supplements
    • 6.1.1.1. Dietary Supplements
    • 6.1.1.2. Herbal Extracts
    • 6.1.1.3. Others
  • 6.1.2. Vitamins & Minerals
• 6.2. Market Analysis, Insights and Forecast - By Dosage Form
  • 6.2.1. Tablets
  • 6.2.2. Capsules
  • 6.2.3. Others
• 6.3. Market Analysis, Insights and Forecast - By Application
  • 6.3.1. Cognitive Function
  • 6.3.2. Stress & Anxiety
  • 6.3.3. Others
• 6.4. Market Analysis, Insights and Forecast - By Distribution Channel
  • 6.4.1. Hospital Pharmacies
  • 6.4.2. Drug Store & Retail Pharmacies
  • 6.4.3. Online Channel
  • 6.4.4. Others
• 6.5. Market Analysis - By Country
  • 6.5.1. U.S.
  • 6.5.2. Canada

7. Europe Brain Health Supplements Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Product Type
  • 7.1.1. Nootropic Supplements
    • 7.1.1.1. Dietary Supplements
    • 7.1.1.2. Herbal Extracts
    • 7.1.1.3. Others
  • 7.1.2. Vitamins & Minerals
• 7.2. Market Analysis, Insights and Forecast - By Dosage Form
  • 7.2.1. Tablets
  • 7.2.2. Capsules
  • 7.2.3. Others
• 7.3. Market Analysis, Insights and Forecast - By Application
  • 7.3.1. Cognitive Function
  • 7.3.2. Stress & Anxiety
  • 7.3.3. Others
• 7.4. Market Analysis, Insights and Forecast - By Distribution Channel
  • 7.4.1. Hospital Pharmacies
  • 7.4.2. Drug Store & Retail Pharmacies
  • 7.4.3. Online Channel
  • 7.4.4. Others
• 7.5. Market Analysis - By Country/Sub-region
  • 7.5.1. U.K.
  • 7.5.2. Germany
  • 7.5.3. France
  • 7.5.4. Spain
  • 7.5.5. Italy
  • 7.5.6. Scandinavia
  • 7.5.7. Rest of Europe

8. Asia Pacific Brain Health Supplements Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Product Type
  • 8.1.1. Nootropic Supplements
    • 8.1.1.1. Dietary Supplements
    • 8.1.1.2. Herbal Extracts
    • 8.1.1.3. Others
  • 8.1.2. Vitamins & Minerals
• 8.2. Market Analysis, Insights and Forecast - By Dosage Form
  • 8.2.1. Tablets
  • 8.2.2. Capsules
  • 8.2.3. Others
• 8.3. Market Analysis, Insights and Forecast - By Application
  • 8.3.1. Cognitive Function
  • 8.3.2. Stress & Anxiety
  • 8.3.3. Others
• 8.4. Market Analysis, Insights and Forecast - By Distribution Channel
  • 8.4.1. Hospital Pharmacies
  • 8.4.2. Drug Store & Retail Pharmacies
  • 8.4.3. Online Channel
  • 8.4.4. Others
• 8.5. Market Analysis - By Country/Sub-region
  • 8.5.1. Japan
  • 8.5.2. Australia
  • 8.5.3. China
  • 8.5.4. India
  • 8.5.5. Southeast Asia
  • 8.5.6. Rest of Asia Pacific

9. Rest of the World Brain Health Supplements Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Product Type
  • 9.1.1. Nootropic Supplements
    • 9.1.1.1. Dietary Supplements
    • 9.1.1.2. Herbal Extracts
    • 9.1.1.3. Others
  • 9.1.2. Vitamins & Minerals
• 9.2. Market Analysis, Insights and Forecast - By Dosage Form
  • 9.2.1. Tablets
  • 9.2.2. Capsules
  • 9.2.3. Others
• 9.3. Market Analysis, Insights and Forecast - By Application
  • 9.3.1. Cognitive Function
  • 9.3.2. Stress & Anxiety
  • 9.3.3. Others
• 9.4. Market Analysis, Insights and Forecast - By Distribution Channel
  • 9.4.1. Hospital Pharmacies
  • 9.4.2. Drug Store & Retail Pharmacies
  • 9.4.3. Online Channel
  • 9.4.4. Others

10. Competitive Analysis

• 10.1. Global Market Share Analysis (2025)
• 10.2. Company Profiles
  • 10.2.1. Alternascript
    • 10.2.1.1. Overview
    • 10.2.1.2. Products & Services
    • 10.2.1.3. SWOT Analysis
    • 10.2.1.4. Recent Developments
    • 10.2.1.5. Strategies
    • 10.2.1.6. Financials (Based on Availability)
  • 10.2.2. Natrol, LLC.
    • 10.2.2.1. Overview
    • 10.2.2.2. Products & Services
    • 10.2.2.3. SWOT Analysis
    • 10.2.2.4. Recent Developments
    • 10.2.2.5. Strategies
    • 10.2.2.6. Financials (Based on Availability)
  • 10.2.3. Procera Health
    • 10.2.3.1. Overview
    • 10.2.3.2. Products & Services
    • 10.2.3.3. SWOT Analysis
    • 10.2.3.4. Recent Developments
    • 10.2.3.5. Strategies
    • 10.2.3.6. Financials (Based on Availability)
  • 10.2.4. Reckitt Benckiser Group PLC
    • 10.2.4.1. Overview
    • 10.2.4.2. Products & Services
    • 10.2.4.3. SWOT Analysis
    • 10.2.4.4. Recent Developments
    • 10.2.4.5. Strategies
    • 10.2.4.6. Financials (Based on Availability)
  • 10.2.5. NEUROHACKER COLLECTIVE, LLC
    • 10.2.5.1. Overview
    • 10.2.5.2. Products & Services
    • 10.2.5.3. SWOT Analysis
    • 10.2.5.4. Recent Developments
    • 10.2.5.5. Strategies
    • 10.2.5.6. Financials (Based on Availability)
  • 10.2.6. SOMA Analytics
    • 10.2.6.1. Overview
    • 10.2.6.2. Products & Services
    • 10.2.6.3. SWOT Analysis
    • 10.2.6.4. Recent Developments
    • 10.2.6.5. Strategies
    • 10.2.6.6. Financials (Based on Availability)
  • 10.2.7. Onnit Labs, Inc.
    • 10.2.7.1. Overview
    • 10.2.7.2. Products & Services
    • 10.2.7.3. SWOT Analysis
    • 10.2.7.4. Recent Developments
    • 10.2.7.5. Strategies
    • 10.2.7.6. Financials (Based on Availability)
  • 10.2.8. Natural Factors USA
    • 10.2.8.1. Overview
    • 10.2.8.2. Products & Services
    • 10.2.8.3. SWOT Analysis
    • 10.2.8.4. Recent Developments
    • 10.2.8.5. Strategies
    • 10.2.8.6. Financials (Based on Availability)
  • 10.2.9. Xtend-Life
    • 10.2.9.1. Overview
    • 10.2.9.2. Products & Services
    • 10.2.9.3. SWOT Analysis
    • 10.2.9.4. Recent Developments
    • 10.2.9.5. Strategies
    • 10.2.9.6. Financials (Based on Availability)